CLINICAL_TRIALS
trial_result
· 2017-06-29
Clinical Trial Update: Eplerenone for the Treatment of Central Serous Chorioretinopathy [NA]
Summary
A completed clinical trial investigating eplerenone for central serous chorioretinopathy has results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Wills Eye | Conditions: Central Serous Chorioretinopathy | NA | Status: COMPLETED | Results posted: 2017-06-29